Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...

A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing ...

Regeneron recently presented five-years results from the phase 3 EMPOWER-Lung 1 trial of Libtayo as a first-line treatment ...

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

Those who regularly wear saris and petticoats that are tied around the waist tightly for a long time are prone to skin ...

These small modifications could be warning signs of skin cancer, a disease that affects more than 170,000 people in the UK ...

Researchers have developed AI, called DeepMerkel, which can determine the course and severity of aggressive skin cancers ...

Research demonstrates that AI can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by generating personalzsed ...

Investigators at Mass General Brigham in Massachusetts, US, have reported outcomes from a study of a new immunotherapy for ...

Researchers explored the risks for basal cell carcinoma, squamous cell carcinoma, and melanoma in patients who underwent BMT.

The 30-year cumulative incidence of any cutaneous malignant neoplasm was 27.4% — 18% for BCC, 9.8% for SCC, and 3.7% for melanoma. A higher risk for skin cancer was reported for patients aged 50 ...